On Friday, Anixa Biosciences Inc (NASDAQ: ANIX) was 4.58% up from the session before settling in for the closing price of $3.06. A 52-week range for ANIX has been $2.14 – $5.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -50.00% over the past five years. When this article was written, the company’s average yearly earnings per share was at -23.44%. With a float of $30.55 million, this company’s outstanding shares have now reached $31.15 million.
Let’s look at the performance matrix of the company that is accounted for 5 employees. In terms of profitability, gross margin is 74.36%, operating margin of -8794.23%, and the pretax margin is -8016.67%.
Anixa Biosciences Inc (ANIX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Anixa Biosciences Inc stocks. The insider ownership of Anixa Biosciences Inc is 5.05%, while institutional ownership is 17.39%. The most recent insider transaction that took place on Jul 30 ’24, was worth 66,237. In this transaction Director of this company bought 21,646 shares at a rate of $3.06, taking the stock ownership to the 890,754 shares. Before that another transaction happened on Jul 31 ’24, when Company’s Director bought 5,580 for $3.23, making the entire transaction worth $18,023. This insider now owns 896,334 shares in total.
Anixa Biosciences Inc (ANIX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 7/31/2024, it has been observed that the corporation posted -0.09 earnings per share (EPS) during the time that was better than consensus figure (set at -0.09) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -23.44% per share during the next fiscal year.
Anixa Biosciences Inc (NASDAQ: ANIX) Trading Performance Indicators
You can see what Anixa Biosciences Inc (ANIX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 11.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.39, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.36 in one year’s time.
Technical Analysis of Anixa Biosciences Inc (ANIX)
Anixa Biosciences Inc (NASDAQ: ANIX) saw its 5-day average volume 0.17 million, a positive change from its year-to-date volume of 0.11 million. As of the previous 9 days, the stock’s Stochastic %D was 12.61%. Additionally, its Average True Range was 0.26.
During the past 100 days, Anixa Biosciences Inc’s (ANIX) raw stochastic average was set at 49.75%, which indicates a significant increase from 15.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.64% in the past 14 days, which was lower than the 69.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.25, while its 200-day Moving Average is $3.12. Nevertheless, the first resistance level for the watch stands at $3.51 in the near term. At $3.81, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.98. If the price goes on to break the first support level at $3.04, it is likely to go to the next support level at $2.87. The third support level lies at $2.57 if the price breaches the second support level.
Anixa Biosciences Inc (NASDAQ: ANIX) Key Stats
There are 32,179K outstanding shares of the company, which has a market capitalization of 107.68 million. As of now, sales total 210 K while income totals -9,810 K. Its latest quarter income was 0 K while its last quarter net income were -3,280 K.
